Arthneeti
E

Emami

Q1 FY27Personal Products

Emami Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹403
Market cap₹17.6K Cr
P/E23.2
Updated25 Aug 2026
Read4 min read

What the Q1 FY27 call signalled

1 of 3 strong

RevenueRank 3
MarginRank 3
CapexYes

Not discussed on this call: fundraise, order book.

The short version

Domestic core business grew ~6% in Q1 FY27; hair care at 11%, skin care at 3% (Rajesh Sharma, pg 13). Core domestic business growth expected to improve beyond current ~6% (Rajesh Sharma, page 13).

From Emami's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Rank 3
  • Domestic core business grew ~6% in Q1 FY27; hair care at 11%, skin care at 3% (Rajesh Sharma, pg 13).
  • Management expects better growth in core business for the remainder of the year (Rajesh Sharma, pg 13).
  • Strategic investments portfolio grew 61% and expected to sustain similar growth going forward (Dhruv Aggarwal, pg 5).
  • Start-ups like The Man Company, Brillare showing strong momentum with plans for new launches and expansion (pg 7, 11).
  • Kesh King expected to achieve double-digit growth by year-end after mid-single-digit growth in Q1 (Mohan Goenka, pg 11).
  • International business faced challenges but expected significant recovery and growth in Q3 and Q4 (pg 7).
  • Overall consolidated revenue grew 15% in Q1, signaling positive trajectory (Mohan Goenka, pg 3).
  • Management confident of sustained and profitable growth through FY27 supported by diversified portfolio and innovation (pg 5).

Profitability & Margins

See what Emami said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes
  • Emami has made a significant strategic investment, including about INR 500 crores in Axiom, funded internally from surplus cash.
  • The company plans further investments in strategic start-ups and fast-growing segments, with a committed management focus on such acquisitions.
  • The strategic investment division, including four start-ups, is expected to grow aggressively, targeting INR 750-800 crores revenue by year-end.
  • Emami is actively scouting for incremental acquisition opportunities alongside consolidating recent ones.
  • They are enhancing supply chain planning, inventory management, and distribution visibility and implementing AI-driven sales code systems to improve operational efficiency.
  • Future capex is likely focused on strengthening the diversified portfolio, digital-first brands, e-commerce, and modern trade channels, as implied by ongoing transformation initiatives.
  • The organization may bolster the central team to support strategic investments growth and plug-and-play scaling models.

Top-ranked in Personal Products

Ranked on what management guided this quarter

5x potential
1Honasa Consumer
Rev 2Mar 2
2Godrej Consumer
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 4
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Emami said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided does not explicitly mention any details regarding the current or expected orderbook or pending orders for Emami Limited as of Q1 FY27. However, some related points can be inferred: - International business order execution faced challenges due to West Asia conflict and supply chain disruptions, especially for OTC pain management products. - The company is working to resolve regulatory approvals to move pain management products from India to Middle East markets. - Once resolved, management expects to regain momentum and see significant growth in international markets in Q3 and Q4 FY27. - There is no direct mention of specific orderbook values or pending orders. - The company remains optimistic about growth prospects due to diversified portfolio and ongoing strategic initiatives. If you need detailed orderbook data, it may not be available in this transcript.

Emami — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹925 Cr, net profit ₹143 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Emami Ltd's management said in earlier quarters

Others in Personal Products this season

  • Dabur India Ltd (Q1 FY27)

    The company remains confident about maintaining 14%-15% PAT (profit after tax) growth at consolidated level if double-digit top-line growth continues. Key…

  • Bajaj Consumer Care Ltd (Q1 FY27)

    Recent quarters saw exponential growth: 20% YoY in FY26 and 28% YoY in Q1 FY27, partly due to prior price corrections and strategic actions (Nishita Shanklesha…

  • Colgate-Palmoliv (Q1 FY27)

    Premium segment is a key growth driver, growing 6 times faster than the market; significant opportunity remains as only 19% of toothpaste is currently premium…

  • Godrej Consumer Products Ltd (Q1 FY27)

    The company reported strong broad-based revenue growth of 19% YoY and volume growth of 9%, reflecting healthy demand. Key concall takeaways from Godrej…

Compare:vs Godrej Consumer Products Ltdvs Dabur India Ltdvs Colgate-Palmoliv

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Emami Q1 FY27 results?

Domestic core business grew ~6% in Q1 FY27; hair care at 11%, skin care at 3% (Rajesh Sharma, pg 13). Core domestic business growth expected to improve beyond current ~6% (Rajesh Sharma, page 13).

What is Emami share price analysis?

Emami currently shows a below-average growth signal. The stock trades at a P/E of 23.2 with a market cap of ₹17,573 Cr. Investors should review the full earnings analysis for detailed insights.

Is Emami planning capital expenditure?

Emami has made a significant strategic investment, including about INR 500 crores in Axiom, funded internally from surplus cash.

Keep Emami on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.